Skip to the page

Data / Medical devices / United States / Cordis US Corp.

Cordis US Corp.: FDA-registered device maker in Santa Clara, CA, United States, 1 PMA approval

Cordis US Corp. is registered with the FDA (registration 3004939290) in Santa Clara, CA, United States. It lists 1 device type. The FDA files 1 PMA approval under its listings, the newest dated August 17, 2005. 2 recall events name it as the recalling firm. Registered through 2027. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3004939290
FEI number
3010142363
Address
5452 Betsy Ross Dr, Santa Clara, CA, United States, 95054
Owner or operator
Cordis US Corp. (9056360)
Roles
Manufacturer, Specification developer
First device listed
December 7, 2007
Registered through
2027
Brand names listed
MYNX CONTROL™ VENOUS Vascular Closure Device 6F-12F, Mynx Control Vascular Closure Device, MynxGrip Vascular Closure Device

Devices it lists

DeviceProduct codeClassRoleSource
Device, Hemostasis, VascularMGB3Manufacturer, Specification developeraccessdata.fda.gov

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

ApprovedPMA numberDeviceProduct codeSupplementsLatest decisionSource
August 17, 2005P040044MATRIX VASCULAR CLOSURE SYSTEM (VSG)MGB107May 14, 2026accessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
October 6, 201675376Class IITerminatedThe PAXWIRE Occlusion Balloon System consists of an occlusion catheter, inflation handle and syringes. It is designed for use in the iliofemoral artery to provide temporary occlusion as well as a path for dilator and/or AccessClosure, Inc. (ACI) is voluntarily recalling the PAXWIRE Occlusion Balloon System device because it was made aware from customers that the device may be removed in the absence of vascular sheath across the arteriotomy. This is a deviation from the firm's standard catheterization technique.accessdata.fda.gov
July 13, 201674599Class IITerminated6F/7F MynxGrip Vascular Closure Device; Product Model MX6721, Product Usage: The 6F/7F MynxGrip Vascular Closure Device is indicated for use to seal femoral arterial and femoral venous access sites while reducing times tA total of 70 6F/7F Mynx Grip devices were shipped from a distributor using improper transport/packaging configurations.accessdata.fda.gov

Compare with other makers

Updated May 14, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.